Close Menu

NEW YORK (GenomeWeb) – ACT Genomics today announced it has raised more than $8 million in its first private funding round.

The funds will support further investment in the firm's lineup of molecular diagnostic assays for monitoring cancer and expansions in the firm's sales, marketing, and medical teams.

"The additional capital will allow us to continue building robust molecular assays and [an] innovative bioinformatics engine," ACT Genomics CEO Hua-Chien Chen said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.